Qube Research & Technologies (QRT)’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-13,654
Closed -$820K – 3037
2021
Q1
$820K Buy
+13,654
New +$494K 0.01% 929

Qube Research & Technologies (QRT)'s PAND Position: Q2 2021 in Review

Qube Research & Technologies (QRT) sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 13,654 shares — an estimated $820K sold.

Qube Research & Technologies (QRT) first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $820K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

  • Qube Research & Technologies (QRT) reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 13,654 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $820K.
  • Qube Research & Technologies (QRT) first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Pandion Therapeutics Inc. Common Stock position peaked at $820K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2021, filed 13 Aug 2021.